Noncanonical Differentiation of Memory B Cells Drives Latent Tuberculosis Infection Reactivation Upon Tumor Necrosis Factor‐Alpha Inhibitor Therapy: An Integrative Transcriptomic Study
International Journal of Rheumatic Diseases · 2025
DOI: 10.1111/1756-185x.70311 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Xinyu Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology and Immunology Department, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Latent Tuberculosis, Transcriptome, Memory B Cells, Tumor Necrosis Factor Inhibitors. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Guangdong Provincial Applied Science and Technology Research and Development Program.
Abstract (Originalsprache)
Aim
Tumor necrosis factor inhibitors (TNFi) are widely used for the treatment of autoimmune diseases, with latent tuberculosis infection (LTBI) reactivation being a significant unresolved issue. The pathogenic mechanisms are not fully understood. Integrated transcriptomic analysis could provide insights into monitoring tuberculosis progression after TNFi therapy and help reduce LTBI reactivation.
Methods
We selected six transcriptomic datasets from studies related to TNFi treatment and tuberculosis. Pathway enrichment, pseudotime, and transcription factor analyses were performed to explore the underlying mechanisms.
Results
Our analysis revealed distinct transcriptional changes in memory B cells during tuberculosis progression and TNFi therapy. In active tuberculosis (ATB), ROR1 + memory B cells were identified in a noncanonical differentiation trajectory, characterized by downregulation of B cell‐related genes (e.g., CD22, EBF1, MS4A1), reduced translational capacity, and suppression of immune response pathways, accompanied by upregulation of oxidative phosphorylation, which highlighted metabolic alterations during tuberculosis progression. A similar subtype also emerged in TNFi‐treated patients, suggesting that metabolic reprogramming of memory B cells may disrupt immune balance, thereby contributing to LTBI reactivation and ATB development following TNFi therapy.
Conclusions
The study integrates bioinformatics and single‐cell RNA sequencing to reveal the role of memory B cells in ATB progression and TNFi treatment, offering insights into TNFi‐associated TB susceptibility and potential therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology and Immunology Department, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
- Shenzhen Longhua Institute of Immunology Transformation, Shenzhen, Guangdong, China.
ORCID-Profile: Xinyu Yu, Xiqing Luo, Xianghui Wen, Jinwei Li
Förderung
- Guangdong Provincial Applied Science and Technology Research and Development Program
Zitieren
APA
Yu, X., Liu, D., Luo, X., Wen, X., Chen, Z., Chen, S., Liu, B., Li, J., Zhang, Y., & Gu, J. (2025). Noncanonical Differentiation of Memory B Cells Drives Latent Tuberculosis Infection Reactivation Upon Tumor Necrosis Factor‐Alpha Inhibitor Therapy: An Integrative Transcriptomic Study. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70311
Vancouver
Yu X, Liu D, Luo X, Wen X, Chen Z, Chen S, et al. Noncanonical Differentiation of Memory B Cells Drives Latent Tuberculosis Infection Reactivation Upon Tumor Necrosis Factor‐Alpha Inhibitor Therapy: An Integrative Transcriptomic Study. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70311
BibTeX
@article{Yu2025,
author = {Yu, Xinyu and Liu, Dong and Luo, Xiqing and Wen, Xianghui and Chen, Zena and Chen, Shude and Liu, Budian and Li, Jinwei and Zhang, Yuxuan and Gu, Jieruo},
title = {Noncanonical Differentiation of Memory B Cells Drives Latent Tuberculosis Infection Reactivation Upon Tumor Necrosis Factor‐Alpha Inhibitor Therapy: An Integrative Transcriptomic Study},
journal = {International Journal of Rheumatic Diseases},
year = {2025},
doi = {10.1111/1756-185x.70311}
}
EUVIMED